Stoke Therapeutics Inc (STOK)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.74B
Last updated: Nov 17, 2026 at 4:15 PM ET
Stoke Therapeutics Inc (STOK) Stock Chart
Stoke Therapeutics (STOK) has a latest price of $26.41 on Nov 17, 2026, 34.3% below its 52-week high of $40.22. Its price fell 0.4% over the past 12 months. The month-end price rose 15.2% over the 5 years through Oct 2026, a compound annual rate of 2.9%.
Price Chart
From Jun 2019 to Oct 2026, its highest month-end close was $61.93 in Dec 2020 and its lowest $3.79 in Nov 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart STOK with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for STOK.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 20.0%, and over 6 months it fell 11.8%. The month-end price rose 590.0% over the 3 years through Oct 2026, a compound annual rate of 90.4%.
| Period | Change |
|---|---|
| 1 month | +6.4% |
| 3 months | -20.0% |
| 6 months | -11.8% |
| 12 months | -0.4% |
| 12 months, with dividends | -0.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +590.0% | +90.4% |
| 5 years | +15.2% | +2.9% |
Price by Year
Its best calendar year was 2025, when the price rose 187.8%, and its weakest was 2022, when it fell 61.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $26.29 | -17.2% |
| 2025 | $31.74 | +187.8% |
| 2024 | $11.03 | +109.7% |
| 2023 | $5.26 | -43.0% |
| 2022 | $9.23 | -61.5% |
| 2021 | $23.99 | -61.3% |
| 2020 | $61.93 | +118.7% |
Trading Range
The price is 0.4% above its 50-day average of $26.32 and 14.1% below its 200-day average of $30.75.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $26.41 | |
| 52-week high | $40.22 | -34.3% |
| 52-week low | $22.05 | +19.8% |
| 50-day average | $26.32 | +0.4% |
| 200-day average | $30.75 | -14.1% |
Price Risk
Over 3 years, its largest fall from a peak was 66.3%.
| Measure | Value |
|---|---|
| 1-year beta | 1.00 |
| Largest fall, 1 year | -41.3% |
| Largest fall, 3 years | -66.3% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About STOK
What is STOK's 1-year price change?
Stoke Therapeutics's price fell 0.4% over the past 12 months. With dividends included, the 12-month total return was -0.4%.
What is STOK's 5-year price change?
Stoke Therapeutics's month-end price rose 15.2% over the 5 years through Oct 2026, a compound annual rate of 2.9%. These figures leave out dividends.
What is STOK's 52-week high and low?
Stoke Therapeutics's 52-week high is $40.22 and its 52-week low is $22.05. Its latest price of $26.41 on Nov 17, 2026 is 34.3% below the high.
What is STOK's beta?
Stoke Therapeutics's 1-year beta against the S&P 500 is 1.00, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 41.3%.
Is the STOK chart free?
Yes. Advanced Charting for STOK is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
STOK pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors